ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,000 | -37.9% | 14,275 | +22.3% | 0.00% | – |
| Q3 2020 | $29,000 | -80.3% | 11,673 | -76.1% | 0.00% | -100.0% |
| Q2 2018 | $147,000 | -25.4% | 48,805 | -2.9% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | -3.4% | 50,238 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $204,000 | -32.0% | 49,236 | +0.6% | 0.00% | -50.0% |
| Q3 2017 | $300,000 | +13.6% | 48,930 | +15.3% | 0.00% | 0.0% |
| Q2 2017 | $264,000 | +91.3% | 42,430 | +73.5% | 0.00% | +33.3% |
| Q3 2016 | $138,000 | +5.3% | 24,460 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $131,000 | -26.8% | 23,784 | -1.2% | 0.00% | -25.0% |
| Q1 2016 | $179,000 | +49.2% | 24,084 | +67.2% | 0.00% | +33.3% |
| Q4 2015 | $120,000 | -11.1% | 14,408 | -3.9% | 0.00% | -25.0% |
| Q3 2015 | $135,000 | – | 14,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |